Form D/A — Paralos Bioscience Inc.
0002080259-26-000002 · filed Jun 23, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $1,000,000
- Reported amount sold
- $646,900
- Minimum investment
- $5,000
- Investors
- 5
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Paralos Bioscience Inc.
- CIK
- 2080259
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 570 WESTWOOD PLAZA LAB ROOM 6350
LOS ANGELES, CA 90095 - Phone
- 6177108741
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Irene Chen · Executive OfficerLos Angeles, CA Find on LinkedIn ↗
-
Yanxi Yang · Executive OfficerLos Angeles, CA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗